Clearly, the effects of CRISPLD2 suppression may induce similar transcriptomic changes in lung fibroblasts and yet contribute to even more profound effects on the phenotype of COPD patients. The gene discussed is CRISPLD2; the disease is chronic obstructive pulmonary disease.